ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0937

MRL-lpr Mice Display Altered Nociception: A new model for lupus peripheral neuropathy

Melodie Zaknoun1, Doaa Tehawey1, Baruh Polis1 and Chaim Putterman2, 1Azrieli Faculty of Medicine, Safed, Israel, 2Albert Einstein College of Medicine, Safed, Israel

Meeting: ACR Convergence 2025

Keywords: Mouse Models, Lupus, neuropsychiatric disorders, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0934–0954) Systemic Lupus Erythematosus – Animal Models Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Of the 19 ACR case definitions for NPSLE, seven involve the peripheral nervous system. MRL/lpr mice spontaneously develop anti-dsDNA antibodies, nephritis, and skin disease, as well as depressive-like behavior and cognitive abnormalities (Polis B, Autoimmunity, 57,2024). However, while peripheral neuropathy is common in human lupus (Florica B, Sem Arth Rheum, 203,2011), whether MRL/lpr mice display peripheral nervous system disease has not been carefully studied.

Methods: To better evaluate sensory function and develop an assay to easily monitor the effects of therapeutic interventions, we enhanced traditional rodent nociception testing by incrementally raising the temperature from 40 to 52°C within 180 seconds. The test focuses on paw licking, which signifies the behavioral reaction to the thermal stimulus. This careful modulation allowed us to accurately record the latency, or response time, for the animals to lick their fore- and hind paws. Female MRL/lpr, and age and sex matched congenic control MRL mice, were tested at 6, 8, and 12 weeks of age.Rota-Rod testing was performed using Stanford’s laboratory protocol. Time to fall and speed at fall were both measured for analysis. Female MRL/lpr and age and sex matched congenic control MRL mice were tested at 15 weeks of age. A standard open field test was done where the animals were left to explore the field for 5 minutes in minimum abrasive conditions. The total time spent in the center zone and the total distance traveled by each mouse were measured. Female MRL/lpr and age and sex matched congenic control MRL mice were tested at 15 weeks of age.

Results: Nociception: We found that already at 6 weeks of age, while there is no difference in anti-dsDNA antibody levels or other characteristic clinical or serologic signs of disease activity, MRL/lpr mice exhibited a notable increase in thermal hyperalgesia, as seen by a decreased mean latency until hind paw-licking responses (withdrawal): 82.69+/-15.03 seconds (n=13) compared to the control MRL strain 122+/-15.15 (n=9) (Figure 1) (p < 0.0001, Unpaired t-test). Similar thermal hyperalgesia responses were observed in MRL/lpr mice also at 8-9 weeks (p < 0.0001, Figure 1), and 12 weeks of age (data not shown). Similar testing using a cold plate approach is in process.Rota-rod: No significant differences were observed in the time to fall/speed at fall between the MRL/lpr mice (n=6) and the MRL strain (n=7)(Figure 2), a finding not supporting a difference in proprioception between these strains.Open Field: MRL/lpr showed a significant decrease in total distance traveled in the open field (1348+/-140.1, n=7) compared to the MRL strain (1995+/-263.3, n=7 (p < 0.0001, Unpaired t test), a result not supporting locomotor hyperactivity in the MRL/lpr strain. There was no significant difference observed in the cumulative time spent in the center zone (Figure 3).

Conclusion: MRL/lpr mice display significantly heightened temperature sensitivity already at 6 weeks of age, before many other disease manifestations are evident. Altered nociception may represent an early and sensitive tool to detect peripheral neuronal involvement in this strain, and if confirmed may serve to model the involvement of the peripheral nervous system in SLE.

Supporting image 1Figure 1: Top: Hindpaw licking latency at 6 weeks of age. Bottom: Hindpaw licking latency at 8-9 weeks of age. LPRF, female MRL/lpr mice; MPJF, female MRL/+ mice.

Supporting image 2Figure 2: Top: Time in seconds until the mouse fell off the apparatus. Bottom: Speed recorded at the time of the fall. MPJ and LPR, female MRL/+ and MRL/lpr mice at 15 weeks of age, respectively.

Supporting image 3Figure 3: Bottom: Cumulative time spent in center zone shown in %. Top: Total distance traveled in cm. LPR and MPJ, female MRL/lpr and MRL/+ mice at 15 weeks of age, respectively.


Disclosures: M. Zaknoun: None; D. Tehawey: None; B. Polis: None; C. Putterman: Cullinan, 1, Progentec, 1.

To cite this abstract in AMA style:

Zaknoun M, Tehawey D, Polis B, Putterman C. MRL-lpr Mice Display Altered Nociception: A new model for lupus peripheral neuropathy [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/mrl-lpr-mice-display-altered-nociception-a-new-model-for-lupus-peripheral-neuropathy/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mrl-lpr-mice-display-altered-nociception-a-new-model-for-lupus-peripheral-neuropathy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology